8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab
Biosimilar Data at the American Society of Clinical Oncology (ASCO)
Annual Meeting [Company Update]
1/5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab
Biosimilar Data at the American Society of Clinical Oncology (ASCO)
Annual Meeting [Company Update]
2/5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab
Biosimilar Data at the American Society of Clinical Oncology (ASCO)
Annual Meeting [Company Update]
3/5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab
Biosimilar Data at the American Society of Clinical Oncology (ASCO)
Annual Meeting [Company Update]
4/5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab
Biosimilar Data at the American Society of Clinical Oncology (ASCO)
Annual Meeting [Company Update]
